Andrew Guinigundo
Adult Health · Cincinnati, OHNPI 1124083407
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $133,890 of the $214,688 with a category attached, or 62.4%. Amgen accounts for 62.4% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2022 at $64,076 and has fallen 58.1% since, to $26,841 in 2025. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 512 payments — averaging $419.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$134K
- GSK$43K
- AstraZeneca$12K
- Pharmacosmos Therapeutics Inc.$8K
- Pfizer$6K
- Jazz Pharmaceuticals Inc.$3K
- plus $8K from 29 others
What the payments were for
- Consulting fees$20,3879%
- Speaking & faculty fees$133,89062%
- Travel & lodging$47,63922%
- Food & beverage$12,3956%
- Education$3780%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 287 | $133,908 |
| GSK | 67 | $43,185 |
| AstraZeneca | 35 | $12,003 |
| Pharmacosmos Therapeutics Inc. | 2 | $7,995 |
| Pfizer | 20 | $6,188 |
| Jazz Pharmaceuticals Inc. | 8 | $3,184 |
| Astellas Pharma US Inc | 7 | $1,902 |
| G1 Therapeutics, Inc. | 4 | $1,382 |
| E.r. Squibb & Sons, L.L.C. | 19 | $894 |
| Novartis | 2 | $785 |
| Bristol Myers Squibb | 1 | $591 |
| Janssen Scientific Affairs, LLC | 5 | $429 |
| Array Biopharma Inc | 6 | $419 |
| Eisai Inc. | 6 | $228 |
| Gilead | 5 | $212 |
| Merck | 8 | $186 |
| Sanofi-aventis U.S. LLC | 2 | $180 |
| Regeneron Healthcare Solutions, Inc. | 3 | $145 |
| Tempus AI, Inc | 2 | $127 |
| EMD Serono, Inc. | 1 | $122 |
| Myovant Sciences Inc. | 1 | $95 |
| Legend Biotech USA Inc. | 1 | $90 |
| Sanofi | 3 | $81 |
| Daiichi Sankyo Inc. | 3 | $62 |
| Johnson & Johnson | 3 | $58 |
| AVEO Pharmaceuticals, Inc. | 2 | $40 |
| Iovance Biotherapeutics, Inc. | 1 | $35 |
| Bayer | 1 | $32 |
| Foundation Medicine, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
| Immunocore Limited | 1 | $17 |
| Progenics Pharmaceuticals, Inc. | 1 | $16 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$214,688 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Other adult health in Cincinnati
- Mary Pat BartoszekCincinnati$38K
- Megan GieskeCincinnati$21K
- Melissa BrinkmanCincinnati$8K
- Bonnie MohlerCanton$338K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Teresa ShafferBoardman$102K
- Jesse McClainYoungstown$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.